Capricor Therapeutics Inc (CAPR)
SG&A Expense Growth
54.00%
Quarterly · Period ending:
CAPR SG&A Expense Growth
Latest reported54.00%period ending
Latest reported54.00%period ending
CAPR Quarterly SG&A Growth (QoQ) (0.00% → 54.00%)
Latest values, visible window
High-resolution chart · PNG
CAPR sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 53.9972% | |
| 51.7458% | |
| 1.6877% | |
| 4.4617% | |
| -6.5184% | |
| 41.9796% | |
| 23.3787% | |
| 13.2695% | |
| -24.9002% | |
| 18.7376% | |
| 17.9327% | |
| 5.7356% | |
| -19.5314% | |
| 22.2975% | |
| 8.9468% | |
| 8.8385% | |
| -13.225% | |
| 28.341% | |
| 17.5205% | |
| 0.5953% | |
| -6.0668% | |
| 27.6117% | |
| 14.719% | |
| -19.1626% | |
| 41.4915% | |
| 29.8071% | |
| -3.865% | |
| 9.6204% | |
| -14.8037% | |
| -11.6299% | |
| -12.2319% | |
| 6.8761% | |
| -15.2518% | |
| 12.2779% | |
| 13.6823% | |
| -12.6704% | |
| 4.878% | |
| 3.0329% | |
| -8.4127% | |
| -12.1339% | |
| 32.1659% | |
| 0.6494% | |
| 10.8162% | |
| 5.0204% | |
| -33.6476% | |
| 103.8784% | |
| -16.465% | |
| 23.1258% | |
| -21.8947% | |
| 25.7501% | |
| 20.1902% | |
| 14.4449% | |
| 3.8655% | |
| 74.0692% | |
| -31.3765% | |
| -10.1364% | |
| -11.6095% | |
| -3.6336% | |
| 3.9259% | |
| -4.5924% | |
| -9.0344% | |
| 19.8686% | |
| -27.7326% | |
| 49.0847% | |
| -28.5227% | |
| -9.4017% | |
| -20.8561% | |
| -37.8295% | |
| 202.2912% | |
| -51.0565% | |
| 15.4062% | |
| -14.727% | |
| -19.8528% | |
| 146.1657% | |
| -201.2485% | |
| 353.7761% | |
| 260.4902% | |
| 1,933.7487% | |
| -25.2692% | |
| 14.2271% | |
| 24.6891% | |
| 2.2172% | |
| 148.8928% | |
| -3.4611% | |
| -45.3652% | |
| -46.9981% | |
| 189.2837% | |
| 22.3227% | |
| 16.249% | |
| -54.0917% | |
| 137.715% | |
| -67.4656% | |
| 87.463% | |
| -1.4581% | |
| -55.95% | |
| -26.4284% | |
| 120.0605% | |
| -75.6794% | |
| 0% | |
| -100% |